Skip to main content
Caplight Logo









Harp Diagnostics

Harp Diagnostics

Private
IsraelHealthcare & Life Scienceshttps://www.harpdx.com/

Last Round

Crowdfunding

Feb 5, 2026

Total Funding Raised

$10,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Harp Diagnostics is a health tech company that develops an automated, rapid stool testing platform for home monitoring of gastrointestinal conditions such as Inflammatory Bowel Diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

remote patient monitoringRPMgastrointestinal diagnosticsIBD monitoringhome stool testingmedical devicepoint-of-care testingPOCTdigital healthhealthtechclinical decision supportchronic disease managementdiagnostic hardwareconnected healthmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Harp Diagnostics Comparables

Compare Harp Diagnostics with similar companies based on industry and business-model similarity.

Harp Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Calpro AS
77%
Preventis GmbH
77%
BÜHLMANN Laboratories AG
74%

Harp Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingFeb 5, 2026
GrantApr 10, 2025
SeedDec 1, 2022

Harp Diagnostics Investors

Notable investors and investment history

Harp Diagnostics investors
InvestorRounds
Crohn's & Colitis FoundationGrant
The Trendlines GroupSeed
Mor Research ApplicationsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 5, 2026

    Completed a crowdfunding round of funding.

  • Apr 10, 2025

    $10K grant from Crohn's & Colitis Foundation

Harp Diagnostics Filings

Explore SEC and related filing metadata, where available.

Harp Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Harp Diagnostics's valuation, stock price, and market status.

Is Harp Diagnostics a public or private company?

Harp Diagnostics is a private company.

What is the current stock price of Harp Diagnostics?

Harp Diagnostics is a private company with no public stock price. Caplight tracks Harp Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Harp Diagnostics worth (valuation)?

Valuation information for Harp Diagnostics is not publicly available.

Can I buy Harp Diagnostics stock?

Harp Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Harp Diagnostics's last funding round?

Harp Diagnostics's most recent funding round was Crowdfunding on February 5, 2026.

Who are the main investors in Harp Diagnostics?

Key investors in Harp Diagnostics include The Trendlines Group.

Will Harp Diagnostics IPO soon?

No public IPO plans have been announced for Harp Diagnostics.

How can I track Harp Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Harp Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range2
Year Founded2022
Last FundingFeb 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?